An iridium(iii)-based irreversible protein-protein interaction inhibitor of BRD4 as a potent anticancer agent
Bromodomain-containing protein 4 (BRD4) has recently emerged as an attractive epigenetic target for anticancer therapy. In this study, an iridium(iii) complex is reported as the first metal-based, irreversible inhibitor of BRD4. Complex is able to antagonize the BRD4-acetylated histone protein-prote...
Gespeichert in:
Veröffentlicht in: | Chemical science (Cambridge) 2015-10, Vol.6 (10), p.5400-5408 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!